Our study reveals that lactoferrin and its downstream target NT5DC3 represent a new light in clinical T2D-induced colon cancer prognosis and treatment, underscoring the potential application of natural dietary mediated tumor suppression. This evidence concerns the gene LTF and type 2 diabetes mellitus.